Twist Bioscience (TWST) Inventory Average (2018 - 2026)

Twist Bioscience (TWST) has 9 years of Inventory Average data on file, last reported at $33.2 million in Q1 2026.

• Inventory Average for Q1 2026 came in at $33.2 million, up 49.71% year-over-year; the trailing twelve-month figure through Mar 2026 was $33.2 million (up 49.71% YoY), and the FY2025 annual result was $26.2 million, down 6.69% from the prior year.
• Inventory Average advanced to $33.2 million in Q1 2026 per TWST's latest filing, from $30.6 million in the prior quarter.
• Over five years, Inventory Average peaked at $43.8 million in Q2 2022 and troughed at $22.2 million in Q1 2025.
• A 5-year average of $33.1 million and a median of $31.5 million in 2023 frame the typical range for Inventory Average.
• The sharpest annual moves came in 2022 and 2024: Inventory Average soared 190.05% in 2022, then dropped 27.54% in 2024.
• A 5-year view of Inventory Average shows it stood at $42.0 million in 2022, then dropped by 25.0% to $31.5 million in 2023, then dropped by 24.36% to $23.8 million in 2024, then rose by 28.65% to $30.6 million in 2025, then gained by 8.5% to $33.2 million in 2026.
• Business Quant data shows TWST's Inventory Average at $33.2 million in Q1 2026, $30.6 million in Q4 2025, and $27.1 million in Q3 2025.